ISBN: 9783725880690 - diabetes: comorbidities, therapeutics and insights (2nd edition) (8 Ergebnisse)

- Hardcover
Anbieter: California Books, Miami, FL, USACalifornia Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 89,91
Versand gratisVersand innerhalb von USAAnzahl: Mehr als 20 verfügbar
Zustand: New.

- Hardcover
- Print-on-Demand
Anbieter: Grand Eagle Retail, Bensenville, IL, USAGrand Eagle Retail
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 82,88
Versand gratisVersand innerhalb von USAAnzahl: 1 verfügbar
Hardcover. Zustand: new. Hardcover. Diabetes is one of the most challenging health problems in the 21st century, projected to affect 700 million people by 2045. In the last 15 years, the number of people diagnosed with type 1 diabetes increased by 45%, and those diagnosed with type 2 diabetes increased by 95%. The most devastating effects of diabetes are its chronic complications, which confer a high risk of morbidity and mortality and an increased health system cost burden. Although there is increased awareness and new therapeutic options in the treatment of diabetes, it is still the leading cause of blindness in working-age adults, the leading cause of kidney failure and dialysis, and the leading cause of nontraumatic lower-limb amputations. Although recent trends indicate a decline in certain diabetes-related complications, such as all-cause and cardiovascular mortality, individuals with diabetes continue to face a significantly elevated risk of these outcomes compared to those without the disease. Given this persistent disparity, further efforts are essential to reduce the burden of comorbidities and lower the risk of premature mortality in the diabetic population. In this context, this Reprint brings together the latest research and advancements in the understanding and management of diabetes-related comorbidities, novel therapeutic approaches, and emerging clinical insights. It includes twelve original research articles, one review article, and one systematic review, offering a comprehensive overview of current developments in the field. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

- Hardcover
- Print-on-Demand
Anbieter: PBShop.store US, Wood Dale, IL, USAPBShop.store US
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 82,89
Versand gratisVersand innerhalb von USAAnzahl: Mehr als 20 verfügbar
HRD. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Hardcover
- Print-on-Demand
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes KönigreichPBShop.store UK
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 77,00
EUR 6,97 VersandVersand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
HRD. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Hardcover
- Print-on-Demand
Anbieter: CitiRetail, Stevenage, Vereinigtes KönigreichCitiRetail
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 86,86
EUR 43,95 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
Hardcover. Zustand: new. Hardcover. Diabetes is one of the most challenging health problems in the 21st century, projected to affect 700 million people by 2045. In the last 15 years, the number of people diagnosed with type 1 diabetes increased by 45%, and those diagnosed with type 2 diabetes increased by 95%. The most devastating effects of diabetes are its chronic complications, which confer a high risk of morbidity and mortality and an increased health system cost burden. Although there is increased awareness and new therapeutic options in the treatment of diabetes, it is still the leading cause of blindness in working-age adults, the leading cause of kidney failure and dialysis, and the leading cause of nontraumatic lower-limb amputations. Although recent trends indicate a decline in certain diabetes-related complications, such as all-cause and cardiovascular mortality, individuals with diabetes continue to face a significantly elevated risk of these outcomes compared to those without the disease. Given this persistent disparity, further efforts are essential to reduce the burden of comorbidities and lower the risk of premature mortality in the diabetic population. In this context, this Reprint brings together the latest research and advancements in the understanding and management of diabetes-related comorbidities, novel therapeutic approaches, and emerging clinical insights. It includes twelve original research articles, one review article, and one systematic review, offering a comprehensive overview of current developments in the field. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

- Hardcover
- Print-on-Demand
Anbieter: AussieBookSeller, Truganina, VIC, AustralienAussieBookSeller
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 100,50
EUR 32,96 VersandVersand von Australien nach USAAnzahl: 1 verfügbar
Hardcover. Zustand: new. Hardcover. Diabetes is one of the most challenging health problems in the 21st century, projected to affect 700 million people by 2045. In the last 15 years, the number of people diagnosed with type 1 diabetes increased by 45%, and those diagnosed with type 2 diabetes increased by 95%. The most devastating effects of diabetes are its chronic complications, which confer a high risk of morbidity and mortality and an increased health system cost burden. Although there is increased awareness and new therapeutic options in the treatment of diabetes, it is still the leading cause of blindness in working-age adults, the leading cause of kidney failure and dialysis, and the leading cause of nontraumatic lower-limb amputations. Although recent trends indicate a decline in certain diabetes-related complications, such as all-cause and cardiovascular mortality, individuals with diabetes continue to face a significantly elevated risk of these outcomes compared to those without the disease. Given this persistent disparity, further efforts are essential to reduce the burden of comorbidities and lower the risk of premature mortality in the diabetic population. In this context, this Reprint brings together the latest research and advancements in the understanding and management of diabetes-related comorbidities, novel therapeutic approaches, and emerging clinical insights. It includes twelve original research articles, one review article, and one systematic review, offering a comprehensive overview of current developments in the field. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

- Hardcover
- Print-on-Demand
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 117,12
EUR 35,00 VersandVersand von Deutschland nach USAAnzahl: 2 verfügbar
Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Diabetes is one of the most challenging health problems in the 21st century, projected to affect 700 million people by 2045. In the last 15 years, the number of people diagnosed with type 1 diabetes increased by 45%, and those diagnosed with type 2 diabetes increased by 95%. The most devastating effects of diabetes are its chronic complications, which confer a high risk of morbidity and mortality and an increased health system cost burden. Although there is increased awareness and new therapeutic options in the treatment of diabetes, it is still the leading cause of blindness in working-age adults, the leading cause of kidney failure and dialysis, and the leading cause of nontraumatic lower-limb amputations. Although recent trends indicate a decline in certain diabetes-related complications, such as all-cause and cardiovascular mortality, individuals with diabetes continue to face a significantly elevated risk of these outcomes compared to those without the disease. Given this persistent disparity, further efforts are essential to reduce the burden of comorbidities and lower the risk of premature mortality in the diabetic population. In this context, this Reprint brings together the latest research and advancements in the understanding and management of diabetes-related comorbidities, novel therapeutic approaches, and emerging clinical insights. It includes twelve original research articles, one review article, and one systematic review, offering a comprehensive overview of current developments in the field. …

- Hardcover
- Print-on-Demand
Anbieter: preigu, Osnabrück, Deutschlandpreigu
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 120,85
EUR 70,00 VersandVersand von Deutschland nach USAAnzahl: 5 verfügbar
Buch. Zustand: Neu. Diabetes | Comorbidities, Therapeutics and Insights (2nd Edition) | Buch | Englisch | 2026 | MDPI AG | EAN 9783725880690 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.